255 related articles for article (PubMed ID: 28434268)
1. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries.
Wang KK; Yang Z; Sarkis G; Torres I; Raghavan V
Expert Opin Ther Targets; 2017 Jun; 21(6):627-638. PubMed ID: 28434268
[TBL] [Abstract][Full Text] [Related]
2. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure.
Li Y; Wang Z; Zhang B; Zhe X; Wang M; Bai J; Lin T; Zhang S
Epilepsy Res; 2013 Feb; 103(2-3):205-10. PubMed ID: 22920679
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 as a Biomarker of Human Acute Traumatic Spinal Cord Injury.
Stukas S; Gill J; Cooper J; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Dhall S; Mac-Thiong JM; Wilson JR; Bailey C; Christie S; Dvorak MF; Wellington C; Kwon BK
J Neurotrauma; 2021 Aug; 38(15):2055-2064. PubMed ID: 33504255
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
6. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin C-terminal hydrolase L1 (UCH-L1) loss causes neurodegeneration by altering protein turnover in the first postnatal weeks.
Reinicke AT; Laban K; Sachs M; Kraus V; Walden M; Damme M; Sachs W; Reichelt J; Schweizer M; Janiesch PC; Duncan KE; Saftig P; Rinschen MM; Morellini F; Meyer-Schwesinger C
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7963-7972. PubMed ID: 30923110
[TBL] [Abstract][Full Text] [Related]
8. Citrate-capped gold nanoparticles for the label-free detection of ubiquitin C-terminal hydrolase-1.
Agarwal S; Mishra P; Shivange G; Kodipelli N; Moros M; de la Fuente JM; Anindya R
Analyst; 2015 Feb; 140(4):1166-73. PubMed ID: 25516911
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.
Liu MC; Akinyi L; Scharf D; Mo J; Larner SF; Muller U; Oli MW; Zheng W; Kobeissy F; Papa L; Lu XC; Dave JR; Tortella FC; Hayes RL; Wang KK
Eur J Neurosci; 2010 Feb; 31(4):722-32. PubMed ID: 20384815
[TBL] [Abstract][Full Text] [Related]
10. [The ubiquitin-proteasome system and neurodegeneration].
Wada K; Osaka H; Aoki S; Wang YL
Rinsho Shinkeigaku; 2001 Dec; 41(12):1072-4. PubMed ID: 12235799
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.
Bishop P; Rocca D; Henley JM
Biochem J; 2016 Aug; 473(16):2453-62. PubMed ID: 27515257
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum ubiquitin C-terminal hydrolase-L1 levels in patients with carbon monoxide poisoning.
Pang L; Wu Y; Dong N; Xu DH; Wang DW; Wang ZH; Li XL; Bian M; Zhao HJ; Liu XL; Zhang N
Clin Biochem; 2014 Jan; 47(1-2):72-6. PubMed ID: 24080464
[TBL] [Abstract][Full Text] [Related]
13. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.
Meray RK; Lansbury PT
J Biol Chem; 2007 Apr; 282(14):10567-75. PubMed ID: 17259170
[TBL] [Abstract][Full Text] [Related]
14. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.
McKeon JE; Sha D; Li L; Chin LS
Cell Mol Life Sci; 2015 May; 72(9):1811-24. PubMed ID: 25403879
[TBL] [Abstract][Full Text] [Related]
15. Umbilical cord blood concentrations of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in neonates developing hypoxic-ischemic encephalopathy.
Zaigham M; Lundberg F; Hayes R; Undén J; Olofsson P
J Matern Fetal Neonatal Med; 2016; 29(11):1822-8. PubMed ID: 26135781
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis.
Shahjouei S; Sadeghi-Naini M; Yang Z; Kobeissy F; Rathore D; Shokraneh F; Blackburn S; Manley GT; Wang KKW
Brain Inj; 2018; 32(1):1-17. PubMed ID: 29087740
[TBL] [Abstract][Full Text] [Related]
17. Serum UCH-L1 as a Novel Biomarker to Predict Neuronal Apoptosis Following Deep Hypothermic Circulatory Arrest.
Zhang YP; Zhu YB; Duan DD; Fan XM; He Y; Su JW; Liu YL
Int J Med Sci; 2015; 12(7):576-82. PubMed ID: 26180514
[TBL] [Abstract][Full Text] [Related]
18. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
Lee YC; Hsu SD
Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
[TBL] [Abstract][Full Text] [Related]
19. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders.
Gong B; Leznik E
Drug News Perspect; 2007; 20(6):365-70. PubMed ID: 17925890
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin carboxyl hydrolase L1 significance for human diseases.
Suong DN; Thao DT; Masamitsu Y; Thuoc TL
Protein Pept Lett; 2014 Jul; 21(7):624-30. PubMed ID: 24702261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
